$1.24 (-1.59%)

Volume: 37.798k

Closed: Feb 03, 2023

Hollow Logo Score: 1.793
Celyad SA Stock
$1.24 (-1.59%)

Volume: 37.798k

Closed: Feb 03, 2023

Score Hollow Logo 1.793
NASDAQ:CYAD

Celyad SA Stock Price (Quote)

$1.24 ( -1.59% ) Friday, 3rd Feb 2023

Range Low Price High Price Comment
30 days $0.515 $3.07 Friday, 3rd Feb 2023 CYAD stock ended at $1.24. This is 1.59% less than the trading day before Thursday, 2nd Feb 2023. During the day the stock fluctuated 4.10% from a day low at $1.22 to a day high of $1.27.
90 days $0.460 $3.07
52 weeks $0.460 $3.63

Historical Celyad SA prices

Date Open High Low Close Volume
2023-02-03 $1.22 $1.27 $1.22 $1.24 37 798
2023-02-02 $1.31 $1.40 $1.21 $1.26 65 554
2023-02-01 $1.34 $1.42 $1.25 $1.30 42 175
2023-01-31 $1.40 $1.49 $1.32 $1.35 78 929
2023-01-30 $1.38 $1.46 $1.30 $1.35 111 831
2023-01-27 $1.42 $1.43 $1.26 $1.29 150 555
2023-01-26 $1.66 $1.72 $1.49 $1.57 155 343
2023-01-25 $1.66 $1.80 $1.62 $1.73 138 009
2023-01-24 $1.98 $2.10 $1.48 $1.61 401 892
2023-01-23 $1.95 $2.25 $1.86 $2.07 482 362
2023-01-20 $2.13 $2.18 $1.94 $1.94 784 014
2023-01-19 $2.22 $2.55 $1.91 $2.20 2 780 724
2023-01-18 $2.04 $3.07 $1.89 $2.37 20 142 417
2023-01-17 $1.30 $2.50 $1.13 $1.90 65 344 807
2023-01-13 $0.740 $0.80 $0.730 $0.799 27 522
2023-01-12 $0.703 $0.750 $0.660 $0.660 6 914
2023-01-11 $0.685 $0.685 $0.685 $0.685 311
2023-01-10 $0.700 $0.700 $0.660 $0.685 9 700
2023-01-09 $0.760 $0.760 $0.623 $0.700 12 636
2023-01-06 $0.543 $0.598 $0.543 $0.591 6 100
2023-01-05 $0.517 $0.600 $0.515 $0.515 12 222
2023-01-04 $0.540 $0.540 $0.515 $0.515 7 108
2023-01-03 $0.484 $0.510 $0.484 $0.500 4 974
2022-12-30 $0.470 $0.523 $0.460 $0.493 20 783
2022-12-29 $0.542 $0.577 $0.470 $0.508 41 275
2022-12-28 $0.559 $0.570 $0.559 $0.560 7 818
2022-12-27 $0.590 $0.620 $0.560 $0.580 6 329
2022-12-23 $0.616 $0.635 $0.570 $0.635 10 565
2022-12-22 $0.610 $0.675 $0.560 $0.645 31 903
2022-12-21 $0.750 $0.760 $0.604 $0.722 153 587
2022-12-20 $1.01 $1.05 $1.01 $1.05 6 987
2022-12-19 $0.99 $1.02 $0.99 $1.02 400
2022-12-16 $1.07 $1.07 $0.97 $0.99 2 820
2022-12-15 $1.06 $1.06 $0.97 $1.03 3 589
2022-12-14 $0.99 $1.00 $0.99 $0.99 3 828
2022-12-13 $0.99 $1.01 $0.95 $0.95 5 373
2022-12-12 $1.02 $1.05 $1.02 $1.05 336
2022-12-09 $0.98 $1.04 $0.98 $1.04 1 679
2022-12-08 $0.98 $1.03 $0.98 $1.03 328
2022-12-07 $0.99 $1.03 $0.99 $1.03 5 619
2022-12-06 $0.99 $1.03 $0.99 $1.00 7 607
2022-12-05 $1.00 $1.04 $0.99 $1.00 10 271
2022-12-02 $1.00 $1.04 $0.99 $1.01 4 638
2022-12-01 $1.00 $1.00 $0.98 $0.99 5 213
2022-11-30 $1.02 $1.03 $0.97 $1.00 5 862
2022-11-29 $1.01 $1.06 $1.01 $1.06 2 416
2022-11-28 $1.08 $1.08 $1.03 $1.06 1 986
2022-11-25 $1.03 $1.10 $1.03 $1.07 9 084
2022-11-23 $1.03 $1.05 $1.02 $1.02 1 950
2022-11-22 $1.10 $1.16 $1.03 $1.08 14 853

Hot Stocks To Watch:

About Celyad SA

Celyad SA Celyad Oncology SA, a clinical-stage biopharmaceutical company, focuses on the discovery and development of chimeric antigen receptor T (CAR-T) cell therapies for the treatment of cancer. Its lead product candidates include CYAD-101, an allogeneic CAR-T candidate that is in Phase 1b clinical trial for the treatment of metastatic colorectal cancer; CYAD-211, a short hairpin RNA (shRNA)-based allogeneic CAR-T candidate, which is in Phase 1 clinical... CYAD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT